Stockreport

Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal [Yahoo! Finance]

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report
PDF Germany's Merck agreed to acquire U.S. biopharmaceutical company SpringWorks Therapeutics for around $3.9 billion, in a bid to expand its oncology and rare disease busin [Read more]